tradingkey.logo
tradingkey.logo
Search

Valneva Announces Positive Immunogenicity And Safety Data For Lyme Vaccine

ReutersSep 3, 2025 5:05 AM
facebooktwitterlinkedin

- Valneva SE VLS.PA:

  • ANNOUNCES POSITIVE IMMUNOGENICITY AND SAFETY DATA FOR LYME VACCINE

  • VLA15-221 PHASE 2 STUDY SHOWS SIGNIFICANT ANTIBODY RESPONSE ACROSS SEROTYPES

  • PFIZER AIMS TO SUBMIT BLA TO FDA AND MAA TO EMA IN 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI